On Simple Names and Complex Diseases: Processing Fluency, Not Representativeness, Influences Evaluation of Medications

The impact of medication names on consumer’s evaluations and intentions is still uncertain. Two experiments demonstrate that complex names are perceived as more harmful compared to simple names and reduce willingness-to-buy. This effect is not limited to the type of medication (OTC or prescription drug) or disease (simple or complex).



Citation:

Simone Dohle and Michael Siegrist (2011) ,"On Simple Names and Complex Diseases: Processing Fluency, Not Representativeness, Influences Evaluation of Medications", in NA - Advances in Consumer Research Volume 39, eds. Rohini Ahluwalia, Tanya L. Chartrand, and Rebecca K. Ratner, Duluth, MN : Association for Consumer Research, Pages: 451-452.

Authors

Simone Dohle, ETH Zurich, Switzerland
Michael Siegrist, ETH Zurich, Switzerland



Volume

NA - Advances in Consumer Research Volume 39 | 2011



Share Proceeding

Featured papers

See More

Featured

Trust in Doubt: Co-Chair's Invited Panel

Adam Berinsky, Massachusetts Institute of Technology, USA
John Gray, MentionMapp.com
Andre Spicer, City University of London, UK

Read More

Featured

E13. Rooting for Rocky or Apollo? Underdog Narratives and Crowdfunding Success

Hua (Meg) Meng, Longwood University, USA
César Zamudio, Kent State University, USA
Yiru Wang, Kent State University, USA

Read More

Featured

The Trusted Influencer: How They Do It and How Brands Can Benefit

Gillian Brooks, Oxford University, UK
Mikolaj Piskorski, IMD

Read More

Engage with Us

Becoming an Association for Consumer Research member is simple. Membership in ACR is relatively inexpensive, but brings significant benefits to its members.